Rick Lozano is the Vice President of Biosimilars & Integrated Business Development for AmerisourceBergen. His responsibilities span across AmerisourceBergen, working with internal teams and manufacturer partners to create and manage innovative biosimilar and follow-on biologic manufacturer relationships. In addition to his leadership in biosimilars, Mr. Lozano leads the team connecting AmerisourceBergen’s diverse manufacturer sourcing and commercialization capabilities across all types of products to expand existing manufacturer partnerships and forge new business development opportunities.

In his previous role as the Vice President of Business Development for the legacy AmerisourceBergen Specialty Group, Rick worked across the enterprise to unify AmerisourceBergen’s work with manufacturers to become the best product commercialization partner across the lifecycle of a pharmaceutical product. Rick joined the AmerisourceBergen team in 2012, where he held leadership roles focused on fostering ION Solution’s relationships with its manufacturer partners and strategic accounts. 

Before that, he spent 14 years in the pharmaceutical industry—including roles at Dendreon Corporation, AMAG Pharmaceuticals and Johnson & Johnson.